Glenmede Trust’s Immunomedics Inc IMMU Stock Holding History

Glenmede Trust’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,410	Closed	-$119K	–	2560
2020 Q3	$119K	Sell	1,410 -834	-37%	-$42.2K	﹤0.01%	1129
2020 Q2	$79K	Sell	2,244 -2,289	-50%	-$66.9K	﹤0.01%	1215
2020 Q1	$95K	Hold	4,533	–	–	﹤0.01%	1438
2019 Q4	$95K	Buy	4,533 +472	+12%	+$8.33K	﹤0.01%	1438
2019 Q3	$53	Hold	4,061	–	–	﹤0.01%	1639
2019 Q2	$56	Buy	4,061 +1,583	+64%	+$23.8K	﹤0.01%	1628
2019 Q1	$47	Buy	+2,478	New	+$39.9K	﹤0.01%	1717
2018 Q3	–	Sell	-497	Closed	-$12K	–	1932
2018 Q2	$12K	Buy	+497	New	+$9.99K	﹤0.01%	1860

Glenmede Trust's IMMU Position: Q4 2020 in Review

Glenmede Trust sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,410 shares — an estimated $119K sold.

Glenmede Trust first reported a position in IMMU in Q2 2018 and held it in 8 quarters. The position peaked at $119K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Glenmede Trust reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 1,410 Immunomedics Inc shares in Q4 2020, an estimated $119K.
Glenmede Trust first reported a position in Immunomedics Inc in Q2 2018 and held it in 8 quarters.
Glenmede Trust's Immunomedics Inc position peaked at $119K in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.